Multicentre, double-blind, randomized study of mitiglinide compared with nateglinide in type 2 diabetes mellitus patients in China.

PubWeight™: 0.77^‹?›

🔗 View Article (PMID 19589264)

Published in J Int Med Res on July 10, 2009

Authors

X Gao¹, Mitiglinide Versus Nateglinide Comparison Study Group

Author Affiliations

1: Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China. gao.xin@zs-hospital.sh.cn

Articles citing this ↘

Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide. Cardiovasc Diabetol (2012) 0.86

Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes (2013) 0.75